| UltraShape Appoints Kristine Foss as Vice President Regulatory and Clinical |
| Giovedì 01 Febbraio 2007 00:00 |
|
Yoqneam, Israel, February 1, 2007 - UltraShape Ltd., industry leader in the body contouring market and the first to market a clinically proven, non-invasive body contouring treatment based on focused ultrasound, announced today the appointment of Kristine Foss as Vice President Regulatory and Clinical. Ms. Foss will lead the company's global regulatory and clinical activities, with a special focus on the company's regulatory strategy in the United States, in addition to maintaining company adherence to all regulatory requirements, and management of the company's global clinical programs. Ms. Foss previously served as Vice President Clinical and Regulatory Affairs at Mentor Corporation, where she successfully secured PMA approval for the company’s silicone gel-filled breast implants, one of the most important regulatory milestones in Mentor’s history in the aesthetics industry. Previous to that, Ms. Foss served at several leading medical device and pharmaceutical companies in the same position, successfully attaining regulatory approvals and promoting the companies' clinical programs. About UltraShapeUltraShape, based in Israel, develops and markets the only clinically proven, non-invasive, focused ultrasound solution for body contouring. Thousands of satisfied patients around the world have already enjoyed measurable results. Contact:Sandra Ziv Amanda McNulty Sheldon Dariela Roffe |